James F Emigh - Net Worth and Insider Trading
James F Emigh Net Worth
The estimated net worth of James F Emigh is at least $659 dollars as of 2024-11-05. James F Emigh is the VP Corporate Development of Acura Pharmaceuticals Inc and owns about 439,660 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $659. Details can be seen in James F Emigh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James F Emigh has not made any transactions after 2017-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James F Emigh
James F Emigh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James F Emigh owns 1 companies in total, including Acura Pharmaceuticals Inc (ACUR) .
Click here to see the complete history of James F Emigh’s form 4 insider trades.
Insider Ownership Summary of James F Emigh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2020-01-02 | VP & Corporate Development |
James F Emigh Latest Holdings Summary
James F Emigh currently owns a total of 1 stock. James F Emigh owns 439,660 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $659.
Latest Holdings of James F Emigh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 439,660 | 0.00 | 659 |
Holding Weightings of James F Emigh
James F Emigh Form 4 Trading Tracker
According to the SEC Form 4 filings, James F Emigh has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 400,000 shares on December 14, 2017, which cost James F Emigh around $40,000.
Insider Trading History of James F Emigh
- 1
James F Emigh Trading Performance
GuruFocus tracks the stock performance after each of James F Emigh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James F Emigh is 67.65%. GuruFocus also compares James F Emigh's trading performance to market benchmark return within the same time period. The performance of stocks bought by James F Emigh within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James F Emigh's insider trading performs compared to the benchmark.
Performance of James F Emigh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 58.82 | | | | | |
| Relative Return to S&P 500(%) | 53.76 | | | | | |
James F Emigh Ownership Network
Ownership Network List of James F Emigh
Ownership Network Relation of James F Emigh
James F Emigh Owned Company Details
What does Acura Pharmaceuticals Inc do?
Who are the key executives at Acura Pharmaceuticals Inc?
James F Emigh is the VP & Corporate Development of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Treasurer & Controller Robert A Seiser , President & CEO Robert B Jones , and VP Pharmaceutical Sciences APT Albert W Brzeczko .
Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acura Pharmaceuticals Inc Insider Transactions
James F Emigh Mailing Address
Above is the net worth, insider trading, and ownership report for James F Emigh. Currently GuruFocus does not have mailing address information for James F Emigh.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
